Trgovina Geron - GERN CFD
Dodaj med priljubljene- Povzetek
- Zgodovinski podatki
- Dogodki
- Izkaz poslovnega izida
- Bilanca stanja
- Denarni tok
- Lastništvo
Razmik | 0.0236 | ||||||||
Nočna pristojbina za nakup
Long position overnight fee
Pojdi na platformo | -0.024068% | ||||||||
Nočna pristojbina za prodajo
Short position overnight fee
Pojdi na platformo | 0.001846% | ||||||||
Čas nočne pristojbine | 21:00 (UTC) | ||||||||
Min. tržena količina | 1 | ||||||||
Valuta | USD | ||||||||
Kritje | 20% | ||||||||
Borza | United States of America | ||||||||
Provizija na trgovanje | 0% |
*Information provided by Capital.com
Predhodno. Zapri* | 2.3328 |
Odpri* | 2.3029 |
Enoletna sprememba* | 95.16% |
Dnevni razpon* | 2.1833 - 2.3029 |
Razpon 52 wk | 1.17-3.84 |
Povprečni obseg (10 dni) | 7.25M |
Povprečni obseg (3 meseci) | 187.15M |
Tržna kapitalizacija | 1.19B |
Razmerje P/E | -100.00K |
Število delnic v obtoku | 508.72M |
Prihodki | 1.53M |
EPS | -0.36 |
Dividenda (donosnost v %) | N/A |
Beta | 0.96 |
Datum naslednjega zaslužka | May 8, 2023 |
Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Zapiranje | Change | Change (%) | Odpiranje | High | Low |
---|---|---|---|---|---|---|
Mar 27, 2023 | 2.3328 | 0.0199 | 0.86% | 2.3129 | 2.3627 | 2.2929 |
Mar 24, 2023 | 2.3228 | 0.0498 | 2.19% | 2.2730 | 2.3328 | 2.2331 |
Mar 23, 2023 | 2.2630 | -0.0299 | -1.30% | 2.2929 | 2.3328 | 2.1932 |
Mar 22, 2023 | 2.2630 | -0.0399 | -1.73% | 2.3029 | 2.4026 | 2.2431 |
Mar 21, 2023 | 2.3129 | -0.1395 | -5.69% | 2.4524 | 2.4624 | 2.3129 |
Mar 20, 2023 | 2.4425 | -0.0598 | -2.39% | 2.5023 | 2.5023 | 2.3926 |
Mar 17, 2023 | 2.4923 | -0.1496 | -5.66% | 2.6419 | 2.6419 | 2.3527 |
Mar 16, 2023 | 2.6419 | 0.0399 | 1.53% | 2.6020 | 2.7017 | 2.5721 |
Mar 15, 2023 | 2.6120 | -0.0399 | -1.50% | 2.6519 | 2.7316 | 2.5821 |
Mar 14, 2023 | 2.7316 | 0.0499 | 1.86% | 2.6817 | 2.7914 | 2.6718 |
Mar 13, 2023 | 2.6718 | 0.1595 | 6.35% | 2.5123 | 2.6718 | 2.5023 |
Mar 10, 2023 | 2.5621 | -0.0997 | -3.75% | 2.6618 | 2.6618 | 2.4225 |
Mar 9, 2023 | 2.6618 | -0.1396 | -4.98% | 2.8014 | 2.8513 | 2.6319 |
Mar 8, 2023 | 2.8114 | 0.0001 | 0.00% | 2.8113 | 2.8513 | 2.7815 |
Mar 7, 2023 | 2.7715 | -0.0299 | -1.07% | 2.8014 | 2.8313 | 2.7515 |
Mar 6, 2023 | 2.8213 | -0.0499 | -1.74% | 2.8712 | 2.8712 | 2.7815 |
Mar 3, 2023 | 2.8712 | 0.0798 | 2.86% | 2.7914 | 2.9111 | 2.7615 |
Mar 2, 2023 | 2.7914 | 0.0399 | 1.45% | 2.7515 | 2.8213 | 2.7216 |
Mar 1, 2023 | 2.7715 | 0.0200 | 0.73% | 2.7515 | 2.8114 | 2.7515 |
Feb 28, 2023 | 2.7615 | 0.0598 | 2.21% | 2.7017 | 2.7914 | 2.7017 |
Geron Events
Čas (UTC) (UTC) | Država | Dogodek |
---|---|---|
No events scheduled |
- Letni
- Četrtletno
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Skupni prihodki | 1.393 | 0.253 | 0.46 | 1.066 | 1.065 |
Prihodki | 1.393 | 0.253 | 0.46 | 1.066 | 1.065 |
Celotni odhodki iz poslovanja | 115.392 | 77.166 | 72.965 | 30.679 | 30.32 |
Celotna prodaja/splošni/upravni stroški Odhodki | 29.665 | 25.678 | 20.893 | 18.707 | 19.287 |
Raziskave in razvoj | 85.727 | 51.488 | 52.072 | 13.432 | 11.033 |
Nenavadni odhodki (prihodki) | -1.46 | 0 | |||
Prihodki iz poslovanja | -113.999 | -76.913 | -72.505 | -29.613 | -29.255 |
Prihodki (odhodki) od obresti, neto Neoperativni | -3.213 | 1.231 | 4.025 | 2.687 | 1.339 |
Čisti dobiček pred obdavčitvijo | -116.112 | -75.617 | -68.548 | -27.017 | -27.916 |
Čisti dobiček po davkih | -116.112 | -75.617 | -68.548 | -27.017 | -27.916 |
Čisti dobiček pred dodatnimi postavkami | -116.112 | -75.617 | -68.548 | -27.017 | -27.916 |
Čisti dobiček | -116.112 | -75.617 | -68.548 | -27.017 | -27.916 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -116.112 | -75.617 | -68.548 | -27.017 | -27.916 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -116.112 | -75.617 | -68.548 | -27.017 | -27.916 |
Popravljen čisti dobiček | -116.112 | -75.617 | -68.548 | -27.017 | -27.916 |
Popravljene ponderirane povprečne delnice | 327.632 | 271.46 | 190.16 | 176.505 | 159.225 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -0.3544 | -0.27856 | -0.36047 | -0.15307 | -0.17532 |
Dividends per Share - Common Stock Primary Issue | |||||
Popravljen normalizirani dobiček na enoto čistega dobička | -0.3544 | -0.27856 | -0.36047 | -0.16134 | -0.17532 |
Drugo, neto | 1.1 | 0.065 | -0.068 | -0.091 |
Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | |
---|---|---|---|---|---|
Skupni prihodki | 0.297 | 0.073 | 0.123 | 1.04 | 0.109 |
Prihodki | 0.297 | 0.073 | 0.123 | 1.04 | 0.109 |
Celotni odhodki iz poslovanja | 40.245 | 28.049 | 28.798 | 32.022 | 25.783 |
Celotna prodaja/splošni/upravni stroški Odhodki | 15.642 | 7.443 | 6.699 | 7.872 | 7.256 |
Raziskave in razvoj | 24.603 | 20.606 | 22.099 | 24.15 | 18.527 |
Prihodki iz poslovanja | -39.948 | -27.976 | -28.675 | -30.982 | -25.674 |
Prihodki (odhodki) od obresti, neto Neoperativni | -0.965 | -1.251 | -1.367 | -1.029 | -0.946 |
Drugo, neto | -0.138 | 1.11 | -0.056 | -0.006 | -0.077 |
Čisti dobiček pred obdavčitvijo | -41.051 | -28.117 | -30.098 | -32.017 | -26.697 |
Čisti dobiček po davkih | -41.051 | -28.117 | -30.098 | -32.017 | -26.697 |
Čisti dobiček pred dodatnimi postavkami | -41.051 | -28.117 | -30.098 | -32.017 | -26.697 |
Čisti dobiček | -41.051 | -28.117 | -30.098 | -32.017 | -26.697 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -41.051 | -28.117 | -30.098 | -32.017 | -26.697 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -41.051 | -28.117 | -30.098 | -32.017 | -26.697 |
Popravljen čisti dobiček | -41.051 | -28.117 | -30.098 | -32.017 | -26.697 |
Popravljene ponderirane povprečne delnice | 405.237 | 403.869 | 332.067 | 330.869 | 328.934 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -0.1013 | -0.06962 | -0.09064 | -0.09677 | -0.08116 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Popravljen normalizirani dobiček na enoto čistega dobička | -0.1013 | -0.06962 | -0.09064 | -0.09677 | -0.08116 |
- Letni
- Četrtletno
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 187.206 | 199.857 | 141.608 | 166.058 | 95.97 |
Denarna sredstva in kratkoročne naložbe | 183.722 | 196.275 | 139.325 | 163.289 | 94.686 |
Denarna sredstva in ustrezniki | 34.871 | 9.925 | 13.644 | 10.575 | 16.335 |
Kratkoročne naložbe | 148.851 | 186.35 | 125.681 | 152.714 | 78.351 |
Celotne terjatve, neto | 1.763 | 0.722 | 0.802 | 1.168 | 0.436 |
Prepaid Expenses | 1.357 | 2.497 | 1.211 | 1.332 | 0.58 |
Other Current Assets, Total | 0.364 | 0.363 | 0.27 | 0.269 | 0.268 |
Total Assets | 226.034 | 270.728 | 165.517 | 185.284 | 110.313 |
Property/Plant/Equipment, Total - Net | 5.377 | 5.953 | 2.905 | 0.059 | 0.102 |
Property/Plant/Equipment, Total - Gross | 6.027 | 6.566 | 3.748 | 0.838 | 0.822 |
Accumulated Depreciation, Total | -0.65 | -0.613 | -0.843 | -0.779 | -0.72 |
Long Term Investments | 28.651 | 63.748 | 20.04 | 19.167 | 14.241 |
Total Current Liabilities | 45.521 | 30.94 | 28.162 | 7.551 | 6.516 |
Accounts Payable | 6.687 | 6.919 | 1.181 | 0.982 | 0.503 |
Accrued Expenses | 38.834 | 24.021 | 12.712 | 3.959 | 6.013 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 99.618 | 59.781 | 30.362 | 7.551 | 6.516 |
Total Long Term Debt | 49.83 | 24.042 | 0 | 0 | 0 |
Total Equity | 126.416 | 210.947 | 135.155 | 177.733 | 103.797 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | |||
Common Stock | 0.324 | 0.31 | 0.2 | 0.186 | 0.16 |
Additional Paid-In Capital | 1398.01 | 1366.19 | 1214.83 | 1189.19 | 1089.68 |
Retained Earnings (Accumulated Deficit) | -1271.74 | -1155.63 | -1080.01 | -1011.46 | -985.84 |
Other Equity, Total | -0.173 | 0.078 | 0.132 | -0.183 | -0.207 |
Total Liabilities & Shareholders’ Equity | 226.034 | 270.728 | 165.517 | 185.284 | 110.313 |
Total Common Shares Outstanding | 323.732 | 310.567 | 199.815 | 186.393 | 159.877 |
Other Current Liabilities, Total | 0 | 14.269 | 2.61 | ||
Other Long Term Assets, Total | 4.8 | 1.17 | 0.964 | ||
Other Liabilities, Total | 4.267 | 4.799 | 2.2 | ||
Long Term Debt | 49.83 | 24.042 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 175.924 | 187.206 | 179.355 | 201.762 | 215.264 |
Denarna sredstva in kratkoročne naložbe | 166.67 | 183.722 | 176.12 | 198.241 | 211.027 |
Denarna sredstva in ustrezniki | 31.325 | 34.871 | 29.036 | 57.282 | 31.537 |
Kratkoročne naložbe | 135.345 | 148.851 | 147.084 | 140.959 | 179.49 |
Celotne terjatve, neto | 5.239 | 1.763 | 0.61 | 0.714 | 0.759 |
Prepaid Expenses | 3.651 | 1.357 | 2.262 | 2.444 | 3.115 |
Other Current Assets, Total | 0.364 | 0.364 | 0.363 | 0.363 | 0.363 |
Total Assets | 198.421 | 226.034 | 229.097 | 252.175 | 258.608 |
Property/Plant/Equipment, Total - Net | 5.229 | 5.377 | 5.5 | 5.619 | 5.783 |
Long Term Investments | 10.945 | 28.651 | 39.362 | 40.521 | 33.289 |
Other Long Term Assets, Total | 6.323 | 4.8 | 4.88 | 4.273 | 4.272 |
Total Current Liabilities | 46.63 | 45.521 | 38.47 | 37.013 | 28.552 |
Accounts Payable | 6.245 | 6.687 | 4.714 | 3.758 | 4.459 |
Accrued Expenses | 40.385 | 38.834 | 33.756 | 33.255 | 24.093 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 100.934 | 99.618 | 77.544 | 75.969 | 57.446 |
Total Long Term Debt | 50.179 | 49.83 | 34.669 | 34.416 | 24.222 |
Long Term Debt | 50.179 | 49.83 | 34.669 | 34.416 | 24.222 |
Other Liabilities, Total | 4.125 | 4.267 | 4.405 | 4.54 | 4.672 |
Total Equity | 97.487 | 126.416 | 151.553 | 176.206 | 201.162 |
Common Stock | 0.324 | 0.324 | 0.321 | 0.321 | 0.318 |
Additional Paid-In Capital | 1399.71 | 1398.01 | 1390.94 | 1388.91 | 1384.26 |
Retained Earnings (Accumulated Deficit) | -1301.84 | -1271.74 | -1239.72 | -1213.03 | -1183.45 |
Other Equity, Total | -0.711 | -0.173 | 0.016 | 0.003 | 0.035 |
Total Liabilities & Shareholders’ Equity | 198.421 | 226.034 | 229.097 | 252.175 | 258.608 |
Total Common Shares Outstanding | 323.737 | 323.732 | 320.604 | 320.599 | 318.545 |
- Letni
- Četrtletno
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Čisti prihodki/začetna postavka | -116.112 | -75.617 | -68.548 | -27.017 | -27.916 |
Denarna sredstva iz poslovanja | -95.556 | -66.652 | -43.829 | -21.009 | -20.556 |
Denarna sredstva iz poslovanja | 0.215 | 0.158 | 0.064 | 0.059 | 0.076 |
Nedenarne postavke | 9.823 | 8.424 | 5.53 | 6.194 | 8.654 |
Spremembe v obratnem kapitalu | 10.518 | 0.383 | 19.125 | -0.245 | -1.37 |
Denarna sredstva pri naložbenju | 71.947 | -105.32 | 27.4 | -77.718 | 22.97 |
Kapitalski izdatki | -0.207 | -0.401 | -0.413 | -0.016 | 0 |
Celotne druge postavke denarnih tokov pri naložbenju | 72.154 | -104.919 | 27.813 | -77.702 | 22.97 |
Denarna sredstva pri financiranju | 48.556 | 168.346 | 19.499 | 92.968 | 1.111 |
Izdaja (odplačilo) delnic, neto | 23.661 | 144.483 | 19.499 | 92.968 | 1.111 |
Neto sprememba denarnih sredstev | 24.947 | -3.626 | 3.07 | -5.759 | 3.525 |
Izdaja (odplačilo) dolga, neto | 24.895 | 23.863 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -30.098 | -116.112 | -84.095 | -57.398 | -27.824 |
Cash From Operating Activities | -33.974 | -95.556 | -73.388 | -50.548 | -32.734 |
Cash From Operating Activities | 0.057 | 0.215 | 0.154 | 0.101 | 0.048 |
Non-Cash Items | 2.393 | 9.823 | 6.78 | 4 | 1.314 |
Changes in Working Capital | -6.326 | 10.518 | 3.773 | 2.749 | -6.272 |
Cash From Investing Activities | 30.427 | 71.947 | 63.582 | 68.988 | 38.083 |
Capital Expenditures | -0.05 | -0.207 | -0.104 | -0.01 | -0.01 |
Other Investing Cash Flow Items, Total | 30.477 | 72.154 | 63.686 | 68.998 | 38.093 |
Cash From Financing Activities | 0 | 48.556 | 28.917 | 28.917 | 16.263 |
Issuance (Retirement) of Stock, Net | 0 | 23.661 | 18.917 | 18.917 | 16.263 |
Net Change in Cash | -3.546 | 24.947 | 19.111 | 47.357 | 21.612 |
Issuance (Retirement) of Debt, Net | 24.895 | 10 | 10 | ||
Foreign Exchange Effects | 0.001 |
Ime vlagatelja | Vrsta vlagatelja | Odstotek neporavnanih obveznosti | Delnice v lasti | Sprememba delnic | Datum imetništva | Ocena prometa |
---|---|---|---|---|---|---|
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 4.8578 | 24712848 | 634874 | 2022-12-31 | LOW |
Deep Track Capital LP | Hedge Fund | 4.7222 | 24022883 | 16608190 | 2023-01-13 | MED |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 3.8748 | 19712189 | 6204477 | 2022-12-31 | LOW |
Vivo Capital, LLC | Venture Capital | 3.7904 | 19282834 | 4044739 | 2022-12-31 | MED |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 3.7104 | 18875462 | 695155 | 2022-12-31 | LOW |
New Enterprise Associates (NEA) | Venture Capital | 3.2078 | 16318681 | 0 | 2022-12-31 | LOW |
TCG Crossover Management, LLC | Investment Advisor | 2.9853 | 15187073 | 3071147 | 2022-12-31 | MED |
RA Capital Management, LP | Hedge Fund | 2.5418 | 12930711 | -17195588 | 2022-12-31 | LOW |
BioImpact Capital LLC | Investment Advisor/Hedge Fund | 1.6644 | 8466981 | 44399 | 2022-12-31 | LOW |
Boxer Capital, L.L.C. | Hedge Fund | 1.5922 | 8100000 | 8100000 | 2022-12-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.2632 | 6426085 | 249077 | 2022-12-31 | LOW |
EcoR1 Capital, LLC | Hedge Fund | 0.7919 | 4028507 | 1726527 | 2022-12-31 | LOW |
Logos Global Management LLC | Investment Advisor | 0.7863 | 4000000 | 2000000 | 2022-12-31 | HIGH |
Millennium Management LLC | Hedge Fund | 0.752 | 3825746 | 2526953 | 2022-12-31 | HIGH |
Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.5878 | 2990269 | 24659 | 2022-12-31 | LOW |
D. E. Shaw & Co., L.P. | Hedge Fund | 0.3916 | 1992236 | -550643 | 2022-12-31 | MED |
Caption Management, LLC | Hedge Fund | 0.3412 | 1735708 | 727510 | 2022-12-31 | HIGH |
BofA Global Research (US) | Research Firm | 0.3114 | 1584205 | 1065620 | 2022-12-31 | LOW |
Sofinnova Investments, Inc | Venture Capital | 0.2869 | 1459589 | 270381 | 2022-12-31 | MED |
Walleye Capital LLC | Hedge Fund | 0.2601 | 1323378 | 309449 | 2022-12-31 | HIGH |
Zakaj izbrati Capital.com? Številke govorijo same zase.
Capital.com Group500K+
Borzni posredniki
92K+
Aktivne stranke mesečno
$53M+
Mesečni obseg naložb
$30M+
Dvigi vsak mesec
Kalkulator trgovanja
Izračunajte svoj hipotetični P&L, če bi trgovino s CFD odprli na določen datum (izberite datum) in jo zaprli na drug datum (izberite datum).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Geron Company profile
O družbi Geron
Geron Corporation je klinično biofarmacevtsko podjetje v pozni klinični fazi, ki se osredotoča na razvoj in komercializacijo imetelstata, zdravila za hematološke mieloične malignome. Družba posluje z enim segmentom, ki se ukvarja z razvojem terapevtskih izdelkov za onkologijo. Imetelstat je 13-merni oligonukleotid, konjugiran z lipidi, ki je zasnovan tako, da je komplementaren predlogi ribonukleinske kisline (RNK) telomeraze in se nanjo veže z visoko afiniteto ter tako neposredno zavira delovanje telomeraze. Klinične študije imetelstata vključujejo IMerge, preskušanje faze III pri mielodisplastičnih sindromih (MDS) manjšega tveganja, in IMbark, preskušanje faze II pri mielofibrozi srednjega ali visokega tveganja. Podjetje IMpactMF je klinično preskušanje faze III pri refraktarni mielofibrozi (MF), ki še poteka.Podjetje je v preskušanjih faze I zaključilo oceno varnosti, prenašanja, farmakokinetike in farmakodinamičnih učinkov zdravila Imetelstat. t
Industry: | Bio Therapeutic Drugs |
919 East Hillsdale Boulevard
Suite 250
FOSTER CITY
CALIFORNIA 94404
US
Izkaz poslovnega izida
- Annual
- Quarterly
Ljudje gledajo tudi
Še vedno iščete posrednika, ki mu lahko zaupate?
Pridružite se 500.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com